Tenet Healthcare (MEX:THC) YoY EBITDA Growth: 68.75% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:THC Tenet Healthcare Corp MEX:THC
72 GF Score
Price MXN3,547.50
GF Value MXN2,450.54
! 6 Warning Signs
View Full Analysis

What is Tenet Healthcare YoY EBITDA Growth?

Tenet Healthcare MEX:THC 72 YoY EBITDA Growth is 68.75% as of Jun. 2026. GuruFocus rates MEX:THC with a GF Score™ of 72/100 and a GF Value™ of MXN2,450.54. The stock has 6 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Tenet Healthcare's YoY EBITDA Growth for the quarter that ended in Jun. 2026 was 68.75%.

Tenet Healthcare's EBITDA per Share for the three months ended in Jun. 2026 was MXN365.55.

Tenet Healthcare YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Tenet Healthcare's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tenet Healthcare YoY EBITDA Growth Chart

Tenet Healthcare Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 46.20 -21.66 1.13 167.61 -39.47

Tenet Healthcare Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.63 -13.40 0.16 27.43 68.75
MEX:THC
72GF Score
Tenet Healthcare Corp MEX:THC
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tenet Healthcare YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Tenet Healthcare's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(888.857-1468.492)/ | 1468.492 |
=-39.47 %

Tenet Healthcare's YoY EBITDA Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EBITDA Growth (Q: Jun. 2026 )
=(EBITDA per Share (Q: Jun. 2026 )-EBITDA per Share (Q: Jun. 2025 )) / | EBITDA per Share (Q: Jun. 2025 )) |
=(365.547-216.619)/ | 216.619 |
=68.75 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 68.75% mean?
Tenet Healthcare (MEX:THC) has a YoY EBITDA Growth of 68.75% as of Jun. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Tenet Healthcare and its competitors.
Is Tenet Healthcare's YoY EBITDA Growth too high?
Tenet Healthcare's current YoY EBITDA Growth is 68.75%. Overall, Tenet Healthcare has a GF Score™ of 72/100, reflecting its overall financial health beyond just this single metric.
How does Tenet Healthcare's YoY EBITDA Growth compare to DVA and EHC?
Tenet Healthcare's YoY EBITDA Growth of 68.75% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Healthcare Providers & Services company?
A good YoY EBITDA Growth depends on the Healthcare Providers & Services industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Tenet Healthcare and its competitors. Tenet Healthcare's current YoY EBITDA Growth is 68.75%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tenet Healthcare stock overvalued right now?
Tenet Healthcare (MEX:THC) has a current YoY EBITDA Growth of 68.75%. The stock's GF Value™ is MXN2,450.54, compared to a current price of MXN3,547.50 — trading 44.8% above its estimated fair value. The current YoY EBITDA Growth is 68.75%. Tenet Healthcare's overall GF Score™ is 72/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Tenet Healthcare (MEX:THC), the current YoY EBITDA Growth is 68.75% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tenet Healthcare (MEX:THC) Overvalued in 2026?

Based on GuruFocus' analysis, Tenet Healthcare stock appears to be overvalued. The current stock price of MXN3,547.50 is trading 44.8% above its estimated GF Value™ of MXN2,450.54.

Key valuation signals for MEX:THC:

  • YoY EBITDA Growth: 68.75%
  • GF Value™: MXN2,450.54 vs. price of MXN3,547.50 (44.8% above fair value)
  • GF Score™: 72/100 with 6 warning signs

No single metric tells the full story. See the MEX:THC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tenet Healthcare Business Description

Address 14201 Dallas Parkway, Dallas, TX, USA, 75254
Tenet Healthcare is a Dallas-based healthcare services organization. It operates acute and specialty hospitals (50 as of December 2025) and hundreds of ambulatory surgery centers and other outpatient facilities across the US, primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.
72GF Score

Get the complete analysis for MEX:THC

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN3,547.50
Price
MXN2,450.54
GF Value